Company intelligence / Profile preview

STAL

Ownership: Private
Development stage: Other

Overview

Stalin Biotech is a biotechnology company focused on modernizing Traditional Chinese Medicine (TCM) through the integration of advanced scientific methodologies and artificial intelligence. Founded in 2000, the company utilizes an AI-driven platform to decode the complex molecular mechanisms of ancient herbal formulations, aiming to develop standardized, evidence-based therapeutics. By combining network pharmacology and systems biology, Stalin Biotech seeks to bridge traditional wisdom with modern pharmaceutical standards to deliver precision medicine solutions. Their business model centers on unlocking the therapeutic potential of TCM for global healthcare applications.

Modalities: Small moleculeHerbal therapeutics
Industry: Biotech

Beyond the preview

Go deeper on STAL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAL.

Explore the full profile